Magsorbeo Biomedical Corp.
Biotechnology company · Newark, Delaware, United States
Magsorbeo Biomedical Corp. is a biotechnology company headquartered in Newark, Delaware, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $25,000 sold in a notice filed in 2022.
Magsorbeo Biomedical at a glance
What does Magsorbeo Biomedical do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $25,000 sold (2022).
Frequently asked questions about Magsorbeo Biomedical
Where is Magsorbeo Biomedical headquartered?
Magsorbeo Biomedical Corp. is headquartered in Newark, Delaware, United States.
What does Magsorbeo Biomedical do?
Magsorbeo Biomedical Corp. is a biotechnology company.
When was Magsorbeo Biomedical founded?
The earliest incorporation on record for Magsorbeo Biomedical Corp. is in 2021, according to public company registers.
Similar companies
- Toivoa, IncNewark, Delaware, United States
- Cell Podium LLCNewark, New Jersey, United States
- Virion Therapeutics, LLCNewark, Delaware, United States
- Simphotek, Inc.Newark, New Jersey, United States
- Fauna Bio IncorporatedNewark, California, United States
- Kaneka Americas Holding IncNewark, California, United States
- Koi Biotherapeutics Inc.Newark, Delaware, United States
- Nangiotx IncNewark, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences